Aisling Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-274,513
Closed -$12M 14
2019
Q2
$12M Hold
274,513
5.13% 6
2019
Q1
$14.1M Hold
274,513
10.76% 4
2018
Q4
$10.2M Buy
+274,513
New +$10.2M 10.69% 5